scorecard

You Searched For "Gland pharma investors" and got 13 results


Sort By:


Business Insider Latest Story Image
3 mins read

A super hit IPO from 2020 has finally doubled investors' money

Investors who stuck with Gland Pharma despite the ₹6,480 crore initial public offer (IPO) receiving…

Business Insider Latest Story Image
2 mins read

Gland Pharma IPO investors made more than a billion dollars in just 2 days

The shares of Gland pharma are seeing a stellar demand from investors post the IPO listing. The IPO…

Business Insider Latest Story Image
3 mins read

FOMO helps Gland Pharma swell on debut

The ₹6,480 crore initial public offering of the Chinese promoter Fosun Pharma-backed Gland Pharma m…

Business Insider Latest Story Image
3 mins read

Gland Pharma IPO allotment: Here’s how to check share allotment status

After receiving a tepid response from investors, the ₹6,480 crore IPO of Gland Pharma closed on Wed…

Business Insider Latest Story Image
2 mins read

Gland Pharma’s grey market premium rises ahead of listing today

The shares of the recently concluded Gland Pharma IPO are soaring in the grey market ahead of its l…

Business Insider Latest Story Image
3 mins read

Gland Pharma ₹1,250 crore IPO to open next week — sets price band at ₹1,490-1,500

The IPO of Hyderabad-based Gland Pharma, which is promoted by China’s Fosun Pharma, will open next …

Business Insider Latest Story Image
5 mins read

China’s Fosun-owned Gland Pharma IPO opens today— Here’s all you need to know about India’s largest pharmaceutical IPO

The ₹6,500 IPO of Hyderabad-based Gland Pharma is now open for subscription. The company is backed …

Business Insider Latest Story Image
9 mins read

Something weird's going on with the doctors prescribing one of pharma's most controversial blockbuster drugs

"Mallinckrodt's goal has been - and continues to be - to acquire under-resourced, under-utilized pr…

Linette Lopez   


Business Insider Latest Story Image
2 mins read

Do large IPOs guarantee large returns? Data suggests that 18 of India's biggest 30 IPOs did not generate solid returns

While over Rs 50,000 crores have been raised by these share sales so far since 2023, only 22% of th…

Business Insider Latest Story Image
4 mins read

Indian markets see huge sell-off after US Fed says interest rate hike will be sooner than expected

“Participants generally noted that, given their individual outlooks for the economy, the labour …

Business Insider Latest Story Image
4 mins read

Top stocks to watch — RIL, Infosys, Vodafone-Idea, Apollo Hospitals, Emami, Route Mobile, Syngene, and others

Indian stock-market indices are likely to open flat on Friday, led by mixed cues from the global pe…

Business Insider Latest Story Image
6 mins read

'This is the most complicated process I've ever seen': As billions flow into the hottest new area of medicine, top execs say a crisis is brewing

Gene therapy is the hottest area in medicine, offering up the potential to treat or even cure devas…

Emma Court   


Business Insider Latest Story Image
6 mins read

A new kind of cancer treatment works remarkably well for some patients but not others - and researchers want to know why

But even with this level of excitement, and anecdotal cases like Carter and Schoenbauer, there are …

Lydia Ramsey